JPM vs PCVX Stock Comparison

PCVX currently leads JPM in this stock comparison, with AIQ scores of 66 vs 65. The clearest difference is momentum, while JPM has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
JPM
Financial Services
vs
PCVX
Healthcare
JPM
JPMorgan Chase & Co.
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Risk Resilience
Sector
Financial Services
PCVX
Vaxcyte, Inc.
Leads
Price
$63.37
Day move
-2.04%
AIQ Score
66/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between JPM and PCVX?

PCVX leads the current stock comparison as Vaxcyte, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

JPMorgan Chase & Co. vs Vaxcyte, Inc.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

PCVX leads

PCVX leads by 1 AIQ points, primarily on Momentum, but the lead has narrowed from 4 points over 30 sessions.

Fragile: 2 of 5 evidence groups support PCVX, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Weakening
JPM

JPMorgan Chase & Co.

AIQ Score
65/100
AIQ Edge Score
8/10
PCVX

Vaxcyte, Inc.

Leads
AIQ Score
66/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors PCVX over JPM, 66 versus 65 as of Nov 15, 2026. PCVX's advantage is driven primarily by stronger momentum, while JPM holds the stronger risk resilience profile. PCVX also shows the stronger technical structure relative to its 50-day moving average. 2 of 5 covered evidence groups favor PCVX today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. PCVX lead: Weakening — the AIQ differential moved from 4 to 1 points over 30 sessions.

Compare JPMorgan Chase & Co. and Vaxcyte, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

JPM
+138.4%
PCVX
+153.4%

Total return comparison

Growth of $10,000, distributions reinvested

JPM $23,841 · PCVX $25,338

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare JPM and PCVX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

JPM advantage
0
PCVX advantage
  • Risk Resilience87 vs 53
    JPM +34
  • Quality86 vs 54
    JPM +32
  • Momentum70 vs 81
    PCVX +11

2 of 5 evidence groups favor PCVX. PCVX’s edge is concentrated in momentum; JPM keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
PCVX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-18.8%)
  • RSI Midline Rejection — bearish, momentum, short horizon

PCVX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — JPM and PCVX both carry a full feed there.

The central trade-off

PCVX (Vaxcyte, Inc.): the stronger current systematic profile, led by momentum.

JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, quality.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PCVX

PCVX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PCVX

PCVX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

PCVX

PCVX on the Momentum factor, by 11 points.

Lower downside

JPM

JPM on Risk Resilience, by 34 points.

Analyst upside

PCVX

PCVX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureJPMPCVXNote
Implied upside to target+7.8%+93%PCVX has more room
Target dispersion+30.3%+4.1%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2611Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor PCVX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven65 vs 66
FundamentalsEvenEPS growth -27.6% vs -1%; TTM ROE 4.1% vs -11.9%
ValuationNot coveredNot covered
TechnicalsPCVXPrice vs 50-day 1.7% vs 1.8%; vs 200-day 6.6% vs 9.8%
Risk ResilienceJPMRisk Resilience 87 vs 53
Analyst expectationsPCVXTarget upside 7.8% vs 93%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of JPM and PCVX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PCVX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

PCVX lead: Weakening — the AIQ differential moved from 4 to 1 points over 30 sessions.

May 27JPM leads above the line · PCVX leads belowNov 13
Today
PCVX +1
65 vs 66
7 sessions ago
PCVX +2
64 vs 66
30 sessions ago
PCVX +4
63 vs 67
90 sessions ago
JPM +1
64 vs 63

The lead changed hands 7 times in this window, most recently on Oct 5 when PCVX moved ahead of JPM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
PCVXConflicted

5 bullish / 2 bearish / 1 neutral, conflicted

Only PCVX

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.33%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • RSI Midline Rejection — bearish, momentum, short horizon

Both carry 5 more signals that do not separate them: Golden Cross Active, Drawdown Recovery Signal, EMA Ribbon Expansion Bullish, TRIX Bullish Signal, Uptrend Structure Active.

PCVX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

PCVXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.04%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1JPM closes the Momentum gap — currently 11 points behind, the largest single contributor to PCVX's edge.
  2. 2JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
  3. 3PCVX's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 1-point move would eliminate PCVX's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricJPMPCVX
Revenue growth (YoY)-7.6%0%
EPS growth (YoY)-27.6%-1%
Gross margin63.2%0%
Operating margin28.2%0%
Return on equity (TTM)4.1%-11.9%
Debt to equity3.320.09

Performance

PCVX leads 4 of 6 windows
MetricJPMPCVX
1 week (5 sessions)3.5%-0.8%
1 month (20 sessions)1.9%-0.4%
3 months (63 sessions)-4.1%5.2%
6 months (126 sessions)16.2%21%
Year to date7.4%37.3%
1 year (252 sessions)8%37.5%

Technicals

PCVX has the stronger structure
MetricJPMPCVX
RSI (14)56.149.5
ADX (14)1826.6
Price vs 50-day1.7%1.8%
Price vs 200-day6.6%9.8%
Volatility (1M, annualized)27.4%58.3%

Risk

JPM is the more resilient
MetricJPMPCVX
Beta0.781.26
Sharpe ratio0.440.79
Sortino ratio0.611.39
Max drawdown-15.5%-28%
Current drawdown-5.2%-14.2%
Annualized volatility22.7%56.2%
Value at risk (95%)-2.4%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, JPM or PCVX?

On the Algovestiq AIQ Score, PCVX is the stronger of the two as of Nov 15, 2026, scoring 66 against JPM's 65. The edge comes from momentum. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is JPM or PCVX the better buy right now?

PCVX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor PCVX over JPM?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 34 points; JPM leads Quality by 32 points; PCVX leads Momentum by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, JPM or PCVX?

Analyst price targets imply +7.8% upside for JPM and +93% for PCVX, so the Street currently favors PCVX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, JPM or PCVX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, JPM or PCVX?

PCVX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, JPM or PCVX?

PCVX on the Momentum factor, by 11 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, JPM or PCVX?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 34 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is JPM more profitable than PCVX?

JPM leads on the comparable margin measures — gross margin 63.2% vs 0%; operating margin 28.2% vs 0%; ttm roe 4.1% vs -11.9%.

Is PCVX's lead over JPM getting stronger or weaker?

PCVX lead: Weakening — the AIQ differential moved from 4 to 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 7 times in that window, most recently on 2026-10-05, when PCVX moved ahead of JPM.

What would change the JPM vs PCVX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Momentum gap — currently 11 points behind, the largest single contributor to PCVX's edge; JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; PCVX's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 3 points over 30 sessions, and a further 1-point move would eliminate PCVX's advantage entirely.

What do the current signals say about JPM and PCVX?

JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. PCVX: 5 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on JPM is Golden Cross Active (bullish, long horizon). On PCVX it is Golden Cross Active (bullish, long horizon).

Compare JPM and PCVX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.